MARKHAM, ON, May 12 /PRNewswire-FirstCall/ - Innolife Pharma, Inc. (Other OTC:INNP.PK - News) has been in discussion over the previous eight months regarding the formation of a joint venture partnership. INNP has reached a point in these negotiations where final written terms have been submitted on all key issues which could lead to the Company's very first product acquisition. It should be noted that this process evolved methodically over this extended period due to the successful, long term history of the product involved, and the well-established reputation of its founding corporation.
Management anticipates additional forthcoming news and progress updates on the closing of this transaction that can complete great strides in two specific areas. One is the awarding of valuable rights to Innolife Pharma of an industry leading product. This established brand known for innovation and consistency over more than two decades can be launched in a brand new target market for the first time representing the largest market of this type on a global scale. Secondly, but of equal importance, is the solidifying of a joint venture with a partner of great quality and experience. The intention is to unite the market access and distribution capabilities of INNP with the knowledge, leadership, and existing contacts of our potential joint venture partner.
INNP will continue to reveal details of our aggressive strategy geared towards long term growth as they become available. We are confident that a partnership will emerge and start to bring in revenue in the near term based on the high level of negotiations reached with an industry leader in the information technology field. The Company believes that the size of our target market is potentially in excess of US$20 Billion. Updates will also be available on the Company's official corporate web site at www.innolifepharma.com. Please bear with us as the site is still under development, but will be officially launched upon finalization of our partnership and product acquisition.
FORWARD-LOOKING STATEMENTS:
This release contains forward-looking statements within the meaning and pursuant to the Safe Harbor provisions of the Securities Litigation Reform Act of 1995 and involve risks and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product development and acceptance, manufacturing, competition, regulatory and/or other factors, which are outside the control of the Company.
SOURCE Innolife Pharma Inc.
Contacts:
Innolife Pharma, Inc. (905) 943-4938 Email: info@innolifepharma.com
Public Companies Associated with this story: INNP
Knobias Subject Codes Associated with this story: Major Agreements
MARKHAM, ON -- (MARKET WIRE) -- 05/02/07 -- Anti Aging Medical Group Corp. (PINKSHEETS: AAGR) announces that the company has commenced trading under its new name, Innolife Pharma Inc. The new symbol is (PINKSHEETS: INNP).
The Company believes that the name change will better reflect where the company is headed and how they are trying to position themselves. In addition to this, there are a few key positive changes that are currently underway. One of the changes is a brand new website that will be more specific to the current activities that the company is involved in. We will be updating our shareholders in the very short-term.
Forward-Looking Statements:
This release contains forward-looking statements within the meaning and pursuant to the Safe Harbor provisions of the Securities Litigation Reform Act of 1995 and involve risks and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product development and acceptance, manufacturing, competition, regulatory and/or other factors, which are outside the control of the companies.
Distributed by Filing Services Canada and retransmitted by Market Wire
For more information, please contact:
Innolife Pharma Inc. E-mail: Email Contact
Source: Anti Aging Medical Group Corp.
Public Companies Associated with this story: AAGR INNP
Knobias Subject Codes Associated with this story: Symbol/Name Change
RAiDAR alerts Learn More About RAiDAR-LT 05/12/2008 (12:42 ET) OTCPicks.com: OTCPicks.com Daily Market Movers Digest Midday Report for Monday, May 12th CABN, LLEG, INNP, CYPW, DLKM - M2 Communications 05/12/2008 (12:20 ET) Maxwell Media Marketing: Real Stock Discoveries Movers and Shakers for Monday, May 12, 2008 INNP, GWGI, CNEX, BELM, RADN, CMTL - M2 Communications 05/12/2008 (10:55 ET) INNP: New 52-Wk High @ $0.050 up 194.12% - Knobias 05/12/2008 (07:30 ET) Innolife Pharma Provides Initial Update on Negotiations for Significant Product Joint Venture - PR Newswire 08/24/2007 (17:38 ET) INNP: Short Interest UNCHG at 1 in Aug 2007 - Knobias 07/24/2007 (18:56 ET) INNP: Short Interest UP 100.0% to 1 in Jul 2007 - Knobias 06/26/2007 (16:39 ET) INNP: Short Interest DN 100.0% to 0 in Jun 2007 - Knobias 05/25/2007 (01:12 ET) INNP: Short Interest DN 99.9% to 5 in May 2007 - Knobias 05/02/2007 (11:47 ET) AAGR: Commences Name Change to Better Reflect Company Direction - Knobias 05/02/2007 (11:43 ET) Anti Aging Medical Group Corp. Announces Name and Symbol Change - Market Wire 05/02/2007 (06:45 ET) Symbol/Name Changes Expected for May 2, 2007 - Knobias 04/24/2007 (18:01 ET) AAGR: Short Interest UP 704.1% to 8.7K in Apr 2007 - Knobias 04/11/2007 (11:15 ET) AAGR: New 52-Wk Low @ $0.019 dn 5% - Knobias 03/26/2007 (16:46 ET) AAGR: Short Interest UP 100.0% to 1.1K in Mar 2007 - Knobias 03/09/2007 (06:45 ET) Symbol Changes Expected for March 9, 2007 - Knobias 03/08/2007 (16:38 ET) AAGM: Announces Reverse Split - Knobias 03/08/2007 (16:34 ET) Anti Aging Medical Group Corp. Announces Reverse Split - Market Wire 03/08/2007 (14:50 ET) AAGM: Sets 1-250 Reverse Stk Split; Eff Mar 09 - Knobias 03/08/2007 (14:50 ET) AAGM: 1-250 Reverse Stk Split Eff Friday, Mar 09 - Knobias 03/08/2007 (04:36 ET) Anti Aging Medical Group Corp. Announces Reverse Split - Filing Services Canada 01/24/2007 (17:00 ET) AAGM: Short Interest DN 100.0% to 0 in Jan 2007 - Knobias 01/23/2007 (08:30 ET) Anti Aging Medical Group Corp. Reports Corporate Milestones - Market Wire 01/23/2007 (08:30 ET) Anti Aging Medical Group Corp. Reports Corporate Milestones - Filing Services Canada 12/27/2006 (20:00 ET) AAGM: Short Interest UP 100.0% to 1.6K in Dec 2006 - Knobias 11/15/2006 (00:00 ET) Anti Aging Medical Group Corp. Provides Corporate Update - Filing Services Canada
company profile Innolife Pharma Inc.is a specialty pharmaceutical company focused on developing, acquiring and commercializing innovative and scientifically proven products that offer both health maintenance and appearance enhancing benefits to all of us. Nutraceuticals are products that have multiple benefits in terms of revitalization for vision, prostate, bone and joint care as well as memory improvement. The Company is developing a drug delivery based, proprietary, non-prescription topical and oral product line which is fast becoming the industry's leader in the treatment of age resistance. Cosmeceuticals are skin care products which are specifically designed to enhance the appearance of your skin while catering to its needs. ... MORE INFO
CONTACT: Rita Sung (PR/CEO/DIR) Innolife Pharma Inc. 7030 Woodbine Ave Suite # 500 Markham, ON L3R 6G2 P: (905) 943-4938 F: (501) 636-9647 Company Home Page | Email
Pink Sheets No Information QuoteNewsChartsCompany InfoFilingsShort InterestInsider Transactions Inside QuoteBest Bid Best Ask Time of Last Inside Change 0.045 (5000 shares) 0.06 (5000 shares) 3:47 PM
Trade Data / Last Trade 5:20 PMLast Sale 0.06 Change +0.043 % Change +252.94 Tick Up Daily High 0.063 Daily Low 0.019 Opening Price 0.019 Volume 355,779 52 wk. High 0.04 52 wk. Low 0.007 Prev Close 0.017 Dividend 0.00 Yield 0.00 Beta Coefficient 0.41 Trade data delayed 15 minutes. Refresh All Data Contact Information Business Description Innolife Pharma, Inc. 7030 Woodbine Ave. Suite 500 Markham, ONT L3R 6G2 Canada
We are a specialty pharmaceutical company focused on developing, acquiring and commercializing innovative and scientifically-proven products that offer both health maintenance and enhanced esthetics benefits that target the "baby boom" generation.
* Disclosure Category No Information * Primary SIC — Industry Classification 2834 - Pharmaceutical preparations
* State Of Incorporation DE * Jurisdiction Of Incorporation USA * Year Of Incorporation 2002
* Company Officers Rita Sung, President Joyce Li, Secretary
* SEC Reporting Status non-SEC Reporting Company * Fiscal Year End 12/31
* Estimated Market Cap 143,923 as of May 9, 2008 * Outstanding Shares 8,466,068 as of May 3, 2007 * Authorized Shares 3,000,000,000 as of Mar 31, 2007 * Float 6,000,000 as of Mar 31, 2007
* Current Capital Change shs decreased by 1 for 250 split Pay Date: Mar 9, 2007
* Company Notes o Formerly=Anti Aging Medical Group Corp. until 5-07 o Formerly=Balfour Maclaine Corp. until 1-06 o Note=3-1-06 company is in the development stage
* Security Notes o Capital Change=shs decreased by 1 for 1,000 split. Effective date=1-23-06
* Transfer Agent Signature Stock Transfer, Inc. 2301 Ohio Drive Plano, TX 75093
The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Click here to update your company profile.
Anti Aging Medical Group Corp. (AAGM) announces that at the opening of trading on March 9th, 2007, the Company has effected a 1 for 250 reverse split of all of the number of issued and outstanding shares of common stock without correspondingly decreasing the number of authorized shares of common stock. Pursuant to the reverse split, every two hundred & fifty (250) shares of common stock issued and outstanding as of the 9th of March 2007, represent one (1) share of common stock. No fractional shares of common stock shall be issued in connection with the reverse split, and, in lieu thereof, the Company shall round up to the nearest whole share any fraction of a share that any stockholder would otherwise receive. The reverse split will reduce the number of shares of the Company's common stock outstanding from approximately 2.1 billion to approximately 8.5 million shares.
Public Companies Associated with this story: AAGM
Knobias Subject Codes Associated with this story: Important Co. News Stock Split
wow, you remember being asked that everyday for weeks, about 8-9 months ago!!!
how has trading been going lately? i'm still gun-shy and staying away, i don't think we have heard ALL of the mortgage/credit crisis yet...still waiting for the BIG bomb to hit, just a hunch!!! If your trading is going good, thats great...i'm too much of a chicken-sh*t to trade right now